JK
Juber Khan
About Juber Khan
Data last updated:
Juber Khan is a Director at Roffton Pharmaceuticals Private Limited (since 2022). The companies operate in Home Appliances and Healthcare. Roffton Pharmaceuticals Private Limited reported revenue of ₹45,165 (FY 2025). Earlier, Juber Khan was a Director at Bolsron Pharmaceuticals Private Limited (2019–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Roffton Pharmaceuticals Private Limited U52100DL2022PTC395090 | Director | 15 Mar 2022 | 2022 | ₹45,165 (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Bolsron Pharmaceuticals Private Limited U85100RJ2019PTC064017 | Director | 15 Feb 2019 | 2019 | ₹17.1 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Juber Khan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jagjeet Singh | 08363660 | Roffton Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Juber Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Juber Khan
Juber Khan currently holds 1 directorship: Roffton Pharmaceuticals Private Limited (Director, since 15 Mar 2022, revenue ₹45,165 (FY 2025)).
Juber Khan was first appointed on 15 Feb 2019 as Director at Bolsron Pharmaceuticals Private Limited. The most recent appointment on record is 15 Mar 2022 at Roffton Pharmaceuticals Private Limited.
Juber Khan held 1 earlier board appointment: Bolsron Pharmaceuticals Private Limited (Director, 15 Feb 2019 to 07 Mar 2022).
The current boards of Juber Khan's companies include Jagjeet Singh (Roffton Pharmaceuticals Private Limited).